The dulaglutide biosimilar LY05008 demonstrated equivalent efficacy in reducing HbA1c, along with comparable safety and immunogenicity profiles, to the reference drug dulaglutide in Chinese adults ...

Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, ...

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

Trial shows that risk of a major adverse cardiovascular event is eight per cent lower in people on new therapy ...

Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...

礼来公司(NYSE:LLY)于2025年8月7日发布了强劲的第二季度财务业绩，营收同比增长38%至156亿美元。尽管业绩表现出色并上调了全年指引，但公司股价在盘前交易中大幅下跌，跌幅达14.38%至639.01美元，这表明投资者可能对业绩有更高期望， ...

Researchers introduced the PREVENT risk age equations to help determine risk of cardiovascular disease. (JAMA Cardiology) A ...

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

关于复方制剂，也感谢您的提问。正如您在电话会议开始时所听到的，这是我们公司的首要任务。这是为了保护患者安全，也是为了确保法律得到遵守。正如我们提到的，自5月22日起，除极少数情况外，在美国复方制剂是非法的。目前进口到美国的原料药是合法的，而且并非来自获批的工厂。 我不会直接评论任何诉讼，但我要告诉你们，没有任何绝对不可能的事情。你们本周早些时候已经看到，我们就正在采取的法律行动提供了更多见解。当然 ...